{
    "organizations": [],
    "uuid": "ee1bae2aa0a856daaedb4f9c1c5e73755f95ae56",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-stellar-biotechnologies-reports-q2/brief-stellar-biotechnologies-reports-q2-loss-per-share-of-0-90-idUSASC0A030",
    "ord_in_thread": 0,
    "title": "Stellar Biotechnologies Reports Q2 Loss Per Share Of $0.90",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Stellar Biotechnologies Inc:\n* STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER FINANCIAL RESULTS\n* Q2 LOSS PER SHARE $0.90 * STELLAR BIOTECHNOLOGIES - AT MARCH 31, 2018, CO HAD WORKING CAPITAL OF $3.7 MILLION; CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $3.8 MILLION\n* QTRLY TOTAL REVENUES WERE RELATIVELY UNCHANGED AT $0.06 MILLION COMPARED TO THE SAME PERIOD LAST YEAR Source text for Eikon:\nOur ",
    "published": "2018-05-07T20:43:00.000+03:00",
    "crawled": "2018-05-08T16:46:38.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "stellar",
        "biotechnology",
        "inc",
        "stellar",
        "biotechnology",
        "report",
        "second",
        "quarter",
        "financial",
        "result",
        "q2",
        "loss",
        "per",
        "share",
        "stellar",
        "biotechnology",
        "march",
        "co",
        "working",
        "capital",
        "million",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "totaled",
        "million",
        "qtrly",
        "total",
        "revenue",
        "relatively",
        "unchanged",
        "million",
        "compared",
        "period",
        "last",
        "year",
        "source",
        "text",
        "eikon"
    ]
}